Caricamento...
Targeting ornithine decarboxylase by α-difluoromethylornithine inhibits tumor growth by impairing myeloid-derived suppressor cells
α-difluoromethylornithine (DFMO) is currently used in chemopreventive regimens primarily for its conventional direct anti-carcinogenesis activity. However, little is known about the effect of decarboxylase (ODC) inhibition by DFMO on antitumor immune responses. We showed here that pharmacologic bloc...
Salvato in:
| Pubblicato in: | J Immunol |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707077/ https://ncbi.nlm.nih.gov/pubmed/26663722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1500729 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|